Skip to content
Tirzepatide Report
Provider review

Teleios Health Tirzepatide Review: Price, Care and Refunds

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

Teleios Health advertises compounded tirzepatide from $99 per month, with selected prescription and total requiring confirmation.

Standout details

  • Publishes a $99 monthly starting offer
  • Names Lion MD and medical-team members

Things to consider

  • Starting price does not establish all-dose or renewal totals
  • Post-review refunds are discretionary, less $50, with written notice within 24 hours

Teleios Health’s current public program material advertises compounded tirzepatide from $99 per month, including medication, provider consultations and shipping if approved. That is a starting offer, not a verified personal prescription or complete selected-plan quote.3,4

Its published financial conditions distinguish medical nonapproval from canceling after a health review: the former promises a full refund, while the latter describes a possible refund less $50 with a 24-hour written-notice requirement.4,5

Obtain the complete quote before choosing a plan

Ask for the selected medication, preparation, concentration, quantity, usable supply, first charge and ongoing bill. The $99 headline does not establish the rate at every dose, a universal renewal amount or the cost of every optional service.3,4

TopicWhat to know
Starting headlineCompounded tirzepatide from $99/month; confirm selected charge and supply.
Medical nonapprovalFAQ promises a full refund when unsuitable for medication.
Named partnersLion MD and multiple pharmacy partners; confirm actual clinician and dispenser.
Public program material does not establish individual approval or a completed order.

The terms describe a technology platform, Teleios Health, LLC, facilitating independent care and pharmacy services. Charges combine professional services and product fulfillment, with fees generally nonrefundable except as the Refund Policy provides. Confirm whether any separate membership or longer payment commitment applies to the selected offer.6

Separate nonapproval from a change of mind

The FAQ promises a full refund if the provider finds the patient unsuitable for medication. After a completed health review and a written prescription, the refund policy instead says Teleios may refund the payment less a $50 professional fee, provided written email notice arrives within 24 hours of review completion. This is a conditional, discretionary route rather than a blanket full-refund promise.4,5

TopicWhat to know
After health reviewPossible refund less $50; written email notice within 24 hours.
Dispensed medicationNonrefundable; pharmacy concerns should be raised within 48 hours.
Marked deliveredPolicy says no reshipment; obtain applicable carrier-claim instructions.
The post-review route is conditional and differs from medical nonapproval.

Dispensed medication is nonrefundable. The policy tells patients with concerns about dispensed medication to contact the pharmacy within 48 hours. Ask which review-completion timestamp and pharmacy-processing stage apply before relying on the 24-hour window.5

The policy also says medication marked delivered by the carrier cannot be reshipped, and a package lost or stolen after delivery confirmation requires a new order, with a carrier claim available. Obtain the applicable instructions for a shipment problem and keep tracking and package details.5

Named partners do not establish your assignment

The FAQ names Lion MD, with Ana Lisa Carr, MD, and Kelly Tenbrink, MD, as its medical team. It lists Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx and The Pharmacy Hub as pharmacy partners. These are provider disclosures, not independent credential checks or confirmation of the practice, clinician or facility assigned to you.4

The terms allow requesting another pharmacy. Confirm whether using it changes payment or fulfillment arrangements. The coverage material describes national access subject to specific service availability and state rules; confirm your physical location and selected treatment before payment.6,7

The consent says patients must be physically in their home state during the telehealth consultation. The FAQ describes shipment within five to seven business days after approval. These are service conditions, not a guaranteed interval from starting an assessment to receiving medication.4,8

Our assessment

Teleios now publishes more substantive care and financial information than a starting-price headline alone. The selected bill and timing of cancellation remain decisive. Compare TRYM Health, TelePeptide and Ondra Health using the actual preparation and full obligation.

Compounded preparations are not FDA-approved finished drugs. Branded tirzepatide trials do not establish every compounded formulation’s safety or effectiveness.1,2 Read the compounding guide and evidence guide, and discuss side effects, gallbladder concerns and the thyroid warning with your clinician.

See the provider comparison for wider context. This review uses public information without submitting an intake, treatment or a purchase.

Frequently asked questions

Is Teleios tirzepatide always $99 per month?

The current public material advertises a starting offer. Obtain the selected preparation, quantity, renewal amount and any separate service obligation.

When does Teleios retain $50?

Its post-review cancellation route may refund payment less $50 when written notice arrives within 24 hours of review completion. Medical nonapproval has a separate full-refund promise.

Do named pharmacy partners establish my dispenser?

No. The public material lists a network; request the actual facility, pharmacist contact and preparation for the selected prescription.

References(8)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. Teleios Health (2026). Public program: named starting offer and treatment selection. Teleios Health.
  4. Teleios Health (2026). FAQ: included care, clinical team, pharmacy partners and nonapproval. Teleios Health.
  5. Teleios Health (2026). Refund Policy: 24-hour written notice, professional fee and delivery finality. Teleios Health.
  6. Teleios Health (2026). Terms: platform identity, fees and pharmacy choice. Teleios Health.
  7. Teleios Health (2026). State coverage and availability qualifications. Teleios Health.
  8. Teleios Health (2026). Telehealth Consent: physical location and care conditions. Teleios Health.

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.